Active Ingredient: ETHINYL ESTRADIOL; NORGESTIMATE
Proprietary Name: TRI-LO-ESTARYLLA
Dosage Form; Route of Administration: TABLET; ORAL-28
Strength: 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A091232
Product Number: 001
Approval Date: Jun 29, 2015
Applicant Holder Full Name: XIROMED PHARMA ESPANA SL
Marketing Status:
Prescription
Patent and Exclusivity Information